The tariffs, set to take effect from October 1, 2025, target only branded and patented medicines unless the manufacturing companies establish production facilities in the United States.
September 26, 2025
India’s pharmaceutical industry, often called the “Pharmacy of the World”, supplies over 50 per cent of global vaccine demand, 40 per cent of generics to the US, and 25 per cent of medicines in the UK.
September 26, 2025
Trump defended the tariffs as essential to protect US industry from “large-scale flooding” of imports.
September 26, 2025
At the same time, raw material prices are correcting sharply in certain categories, particularly antibiotics, while customers are destocking to take advantage of lower prices.
September 9, 2025
He further stated that the tariff exemption acknowledges the critical role of India’s pharmaceutical industry in global public health, economic stability, and national security.
April 3, 2025Advertisement